secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2024-10-21T23:59:59+00:00
Accession:  0001356576-24-000060
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus sets Q3 2024 earnings call for November 4 after market close
---------------------------------------------------------------------

- Earnings release scheduled for Monday, November 4, 2024, after market close.
- President/CEO Jack Khattar and CFO Tim Dec to host conference call at 4:30 p.m. ET.
- Webcast replay available for 60 days on investor relations website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657624000060/0001356576-24-000060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657624000060/supn-20241021.htm
  HTML page:      https://secwatch.observer/filing/0001356576-24-000060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer